Transport for abciximab facilitated primary angioplasty versus on-site thrombolysis with a liberal rescue policy: The randomised Holland Infarction Study (HIS)

Journal of Thrombosis and Thrombolysis

Volumn 22, Issue 1, 2006, Pages 39-45

  Dieker, Hendrik Jan ^a   van Horssen, Elvira V ^b   Hersbach, Ferry M R J ^d   Brouwer, Marc A ^a   van Boven, Ad J ^b   van't Hof, Arnoud W J ^c   Aengevaeren, Wim R M ^a   Verheugt, Freek W A ^a   Bär, Frits W H M ^d  

^a RADBOUD UNIVERSITY MEDICAL CENTER   (Netherlands)

^b UNIVERSITY MEDICAL CENTER GRONINGEN   (Netherlands)

^c Isalaklinieken Zwolle ^*  (Netherlands)

^d MAASTRICHT UNIVERSITY MEDICAL CENTER   (Netherlands)

Author keywords

Interhospital transport; Myocardial infarction; Primary angioplasty; Thrombolysis

Indexed keywords

ABCIXIMAB; ACETYLSALICYLIC ACID; ALTEPLASE; CLOPIDOGREL; ENOXAPARIN; RETEPLASE; TENECTEPLASE;

ADULT; AGED; ANGIOPLASTY; ARTICLE; BLOOD CLOT LYSIS; CEREBROVASCULAR ACCIDENT; CLINICAL ARTICLE; CLINICAL PROTOCOL; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CORONARY CARE UNIT; FEMALE; FIBRINOLYTIC THERAPY; HEART INFARCTION; HUMAN; INTERMETHOD COMPARISON; MALE; MORTALITY; NETHERLANDS; PATIENT TRANSPORT; PRIORITY JOURNAL; PROGNOSIS; RANDOMIZED CONTROLLED TRIAL; RECURRENT DISEASE; ST SEGMENT ELEVATION; THORAX PAIN; TREATMENT INDICATION; TREATMENT OUTCOME; TREATMENT RESPONSE;

AGED; ANGIOPLASTY; ANTIBODIES, MONOCLONAL; FEMALE; FIBRINOLYTIC AGENTS; HUMANS; IMMUNOGLOBULIN FAB FRAGMENTS; MALE; MIDDLE AGED; MYOCARDIAL INFARCTION; NETHERLANDS; OUTCOME ASSESSMENT (HEALTH CARE); PLATELET GLYCOPROTEIN GPIIB-IIIA COMPLEX; THROMBOLYTIC THERAPY; TRANSPORTATION OF PATIENTS; TREATMENT FAILURE;

EID: 33745261752     PISSN: 09295305     EISSN: None     Source Type: Journal    
DOI: 10.1007/s11239-006-7731-6     Document Type: Article

References (31)

1. Weaver WD, Simes RJ, Betriu A, et al. (1997) Comparison of primary coronary angioplasty and intravenous thrombolytic therapy for acute myocardial infarction. JAMA 278:2093-2098
2. Dieker H, Brouwer MA, van Horssen EV, et al. (2004) Fibrinolysis and primary PCI for ST-elevation myocardial infarction: Call for a more refined perspective. Neth Heart J 12:343-346
3. Andersen HR, Nielsen TT, Rasmussen K, et al. (2003) A comparison of coronary angioplasty with fibrinolytic therapy in acute myocardial infarction. N Engl J Med 349:733-742
4. Antoniucci D, Migliorini A, Parodi G, et al. (2004) Abciximab-supported infarct artery stent implantation for acute myocardial infarction and long-term survival. A prospective, multicentre, randomised trial comparing infarct artery stenting plus abciximab with stenting alone. Circulation 109:1704-1706
5. Montalescot G, Borentain M, Payot L, et al. (2004) Early vs late administration of glycoprotein IIb/IIIa inhibitors in primary coronary intervention of acute ST-segment elevation myocardial infarction. A meta-analysis. JAMA 292:362-366
6. Stone GW, Cox D, Garcia E, et al. (2001) Normal flow (TIMI-3) before mechanical reperfusion therapy is an independent determinant of survival in acute myocardial infarction. Analysis from the primary angioplasty in myocardial infarction trials. Circulation 104:636-641
7. Ellis SG, Da Silva ER, Spaulding CM, et al. (2000) Review of immediate angioplasty after fibrinolytic therapy for acute myocardial infarction: insights from the RESCUE I, RESCUE II, and other contemporary clinical experiences. Am Heart J 139:1046-1053
8. Cannon CP, McCabe CH, Wilcox RG, et al. (2000) Oral glycoprotein IIb/ IIIa inhibition with orbofiban in patients with unstable coronary syndromes (OPUS-TIMI 16) trial. Circulation 102:149-156
9. Schröder R, Zeymer U, Wegschreider K, et al. (1999) Comparison of the predictive value of ST segment elevation resolution at 90 and 180 min after start of streptokinase in acute myocardial infarction: A substudy of the Hirudin for Improvement of Thrombolysis (HIT)-4. Eur Heart J 20:1563-1571
10. Vermeer F, Oude Ophuis AJM, vd Berg EJ, et al. (1999) Prospective randomised comparison between thrombolysis, rescue PTCA, and primary PTCA in patients with extensive myocardial infarction admitted to a hospital without PTCA facilities: A safety and feasibility study. Heart 82:426-431
11. Widimsky P, Groch L, Zelizko M, et al. (2001) Multicentre randomized trial comparing transport to primary angioplasty vs immediate thrombolysis vs combined strategy for patients with acute myocardial infarction presenting to a community hospital without a catheterisation laboratory. The PRAGUE Study. Eur Heart J 21:823-831
12. Widimsky P, Budesinsky T, Vorac D, et al. (2003) Long distance transport for primary angioplasty vs immediate thrombolysis in acute myocardial infarction. Final results of the randomized national multicentre trial-PRAGUE-2. Eur Heart J 24:94-104
13. Grines CL, Westerhausen DR, Grines LL, et al. (2002)A randomized trial of transfer for primary angioplasty versus on-site thrombolysis in patients with high-risk myocardial infarction. The air primary angioplasty in myocardial infarction study. J Am Coll Cardiol 39:1713-1719
14. de Lemos JA, Braunwald E. ST (2001) segment resolution as a tool for assessing the efficacy of reperfusion therapy. J Am Coll Cardiol 38:1283-1294
15. Van't Hof AW, Liem A, de Boer M, et al. (1997) Clinical value of 12-lead electrocardiogram after successful reperfusion therapy for acute myocardial infarction. Lancet 350:615-619
16. Keeley EC, Boura JA, Grines CL (2003) Primary angioplasty versus intravenous thrombolytic therapy for acute myocardial infarction: A quantitative review of 23 randomised trials. Lancet 361:13-20
17. GUSTO Investigators (1993) An international randomized trial comparing four thrombolytic strategies for acute myocardial infarction. N Engl J Med 329:673-682
18. Bär F, Vainer J, Stevenhagen J, et al. (2000) Ten-year experience with early angioplasty in 759 patients with acute myocardial infarction. J Am Coll Cardiol 36:51-58
19. Nallamothu BK, Bates ER, Herrin J, et al. (2005) Times to treatment in transfer patients undergoing primary percutaneous coronary intervention in the United States. National Registry of Myocardial Infarction (NRMI)-3/4 analysis. Circulation 111:761-767
20. Morrison LJ, Verbeek PR, McDonald AC, et al. (2000) Mortality and prehospital thrombolysis for acute myocardial infarction: A meta-analysis. JAMA 283:2686-2692
21. Terkelsen CJ, Lassen JF, Norgaard BL, et al. (2005) Reduction of treatment delay in patients with ST-elevation myocardial infarction: impact of pre-hospital diagnosis and direct referral to primary percutaneous intervention. Eur Heart J 26:770-777
22. Bonnefoy E, Lapostolle F, Leizorovicz A, et al. (2002) Primary angioplasty versus prehospital fibrinolysis in acute myocardial infarction: A randomised study. Lancet 360:825-829
23. Gershlick AH, Stephens-Lloyd A, Hughes S, et al. (2005) Rescue angioplasty after failed thrombolytic therapy for acute myocardial infarction. N Engl J Med 353:2758-2768
24. Assessment of the Safety and Efficacy of New Treatment Strategy with Percutaneous Coronary Intervention (ASSENT-4 PCI) Investigators. (2006) Primary versus tenecteplase-faciltated percutaneous coronary intervention in patients with ST-segment elevation acute myocardial infarction (ASSENT-4 PCI): Randomised trial. Lancet 367:569-578.
25. Ross AM, Coyne KS, Reiner JS, et al. (1999) A randomized trial comparing primary angioplasty with a strategy of short-acting thrombolysis and immediate planned rescue angioplasty in acute myocardial infarction: The PACT trial. J Am Coll Cardiol 34:1954-1962
26. The Assessment of the Safety and Efficacy of a new Thrombolytic regimen (ASSENT)-3 Investigators. Efficacy and safety of tenecteplase in combination with enoxaparin, abciximab, or unfractionated heparin: The ASSENT-3 randomised trial in acute myocardial infarction. Lancet 2001;358:605-613
27. Wallentin L, Goldstein P, Armstrong PW, et al. (2003) Efficacy and safety of tenecteplase in combination with the low-molecular weight heparin enoxaparin or unfractionated heparin in the prehospital setting. The assessment of the safety anf efficacy of a new thrombolytic regimen (ASSENT)-3 PLUS randomized trial in acute myocardial infarction. Circulation 108:135-142
28. Antman EM, Morrow DA, McCAbe CH, et al. (2005) Enoxaparin versus unfractionated heparin as antithrombin therapy in patients receiving fibrinolysis for ST-elevation myocardial infarction: Design and rationale for the Enoxaparin and Thrombolysis reperfusion for acute myocardial infarction treatment-thrombolysis in myocardial infarction study 25 (ExTRACT-TIMI 25). Am Heart J 149:217-224
29. Kereiakes DJ, Grines C, Fry E, et al. Enoxaparin and abciximab adjunctive pharmacotherapy during percutaneous coronary intervention. J Invasive Cardiol 13:272-278
30. Sabatine MS, Cannon CP, Gibson CM, et al. (2005) Addition of clopidogrel to aspirin and fibrinolytic therapy for myocardial infarction with ST-segment elevation. New Engl J Med 352:1179-1189
31. COMMIT collaborative group. (2005) Addition of clopidogrel to aspirin in 45,852 patients with acute myocardial infarction: Randomised placebo-controlled trial. Lancet 366:1607-1621